mPharma

mPharma is a technology-driven healthcare company headquartered in Ghana, founded in 2014. The company's slogan, "We are a technology-driven healthcare company building an Africa that is in good health," reflects its commitment to leveraging technology to improve healthcare in Africa. mPharma focuses on increasing patient access to high-quality medications, offering drug benefits services to health insurance companies and pharmaceutical companies to make medications more affordable for patients. In its latest financing round, mPharma successfully secured a $30.00M Series D investment on 05 January 2022. The round witnessed participation from prominent investors, including Lux Capital, Social Capital, Novastar Ventures, Golden Palm Investments, JAM Fund, Unbound, northstar.vc, and TO Ventures. This significant investment not only underscores investor confidence in mPharma's vision and business model but also provides the company with the necessary capital to further its mission of improving healthcare access in Africa. As a company operating at the intersection of healthcare and technology, mPharma is strategically positioned to address the unique healthcare challenges prevalent in emerging markets, particularly Africa. The recent investment not only validates mPharma's innovative approach but also signals the growing interest of investors in healthcare startups focused on enhancing access and affordability of medications in underserved regions.